137 related articles for article (PubMed ID: 34035314)
1. How different combinations of comorbidities affect healthcare use by elderly patients with obstructive lung disease.
Buja A; Bardin A; Grotto G; Elvini S; Gallina P; Zumerle G; Benini P; Scibetta D; Baldo V
NPJ Prim Care Respir Med; 2021 May; 31(1):30. PubMed ID: 34035314
[TBL] [Abstract][Full Text] [Related]
2. Healthcare Service Usage and Costs for Elderly Patients with Obstructive Lung Disease.
Buja A; Elvini S; Caberlotto R; Pinato C; Mafrici SF; Grotto G; Bicciato E; Baldovin T; Zumerle G; Gallina P; Baldo V
Int J Chron Obstruct Pulmon Dis; 2020; 15():3357-3366. PubMed ID: 33376316
[TBL] [Abstract][Full Text] [Related]
3. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
[TBL] [Abstract][Full Text] [Related]
4. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).
Singh JA; Yu S
Respir Res; 2016 Jan; 17():1. PubMed ID: 26739476
[TBL] [Abstract][Full Text] [Related]
5. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
6. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease.
Li CL; Lin MH; Chen PS; Tsai YC; Shen LS; Kuo HC; Liu SF
Int J Chron Obstruct Pulmon Dis; 2020; 15():389-395. PubMed ID: 32110007
[TBL] [Abstract][Full Text] [Related]
7. Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks.
Yeatts KB; Lippmann SJ; Waller AE; Hassmiller Lich K; Travers D; Weinberger M; Donohue JF
Chest; 2013 Sep; 144(3):784-793. PubMed ID: 23579283
[TBL] [Abstract][Full Text] [Related]
8. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization.
Terzano C; Colamesta V; Unim B; Romani S; Meneghini A; Volpe G; La Torre G
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3680-3689. PubMed ID: 28925473
[TBL] [Abstract][Full Text] [Related]
9. Contributions of COPD, asthma, and ten comorbid conditions to health care utilization and patient-centered outcomes among US adults with obstructive airway disease.
Murphy TE; McAvay GJ; Allore HG; Stamm JA; Simonelli PF
Int J Chron Obstruct Pulmon Dis; 2017; 12():2515-2522. PubMed ID: 28883718
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong - computerized data collection and analysis.
Chan HS; Ko FWS; Chan JWM; So LKY; Lam DCL; Chan VL; Tam CY; Yu WC
Int J Chron Obstruct Pulmon Dis; 2018; 13():1913-1925. PubMed ID: 29942124
[TBL] [Abstract][Full Text] [Related]
11. History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.
Sadatsafavi M; Tavakoli H; Kendzerska T; Gershon A; To T; Aaron SD; FitzGerald JM;
Ann Am Thorac Soc; 2016 Feb; 13(2):188-96. PubMed ID: 26599154
[TBL] [Abstract][Full Text] [Related]
12. Emergency Department Visits and Disease Burden Attributable to Ambulatory Care Sensitive Conditions in Elderly Adults.
Hsieh VC; Hsieh ML; Chiang JH; Chien A; Hsieh MS
Sci Rep; 2019 Mar; 9(1):3811. PubMed ID: 30846843
[TBL] [Abstract][Full Text] [Related]
13. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure.
Braunstein JB; Anderson GF; Gerstenblith G; Weller W; Niefeld M; Herbert R; Wu AW
J Am Coll Cardiol; 2003 Oct; 42(7):1226-33. PubMed ID: 14522486
[TBL] [Abstract][Full Text] [Related]
14. COPD exacerbations in the emergency department: Epidemiology and related costs. A retrospective cohort multicentre study from the Italian Society of Emergency Medicine (SIMEU).
Germini F; Veronese G; Marcucci M; Coen D; Ardemagni D; Montano N; Fabbri A;
Eur J Intern Med; 2018 May; 51():74-79. PubMed ID: 29371059
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity profile and healthcare utilization in elderly patients with serious mental illnesses.
Hendrie HC; Lindgren D; Hay DP; Lane KA; Gao S; Purnell C; Munger S; Smith F; Dickens J; Boustani MA; Callahan CM
Am J Geriatr Psychiatry; 2013 Dec; 21(12):1267-76. PubMed ID: 24206938
[TBL] [Abstract][Full Text] [Related]
16. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
17. Inequities in ambulatory care and the relationship between socioeconomic status and respiratory hospitalizations: a population-based study of a canadian city.
Trachtenberg AJ; Dik N; Chateau D; Katz A
Ann Fam Med; 2014; 12(5):402-7. PubMed ID: 25354403
[TBL] [Abstract][Full Text] [Related]
18. Can a telemonitoring system lead to decreased hospitalization in elderly patients?
Lyth J; Lind L; Persson HL; Wiréhn AB
J Telemed Telecare; 2021 Jan; 27(1):46-53. PubMed ID: 31291794
[TBL] [Abstract][Full Text] [Related]
19. Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure.
Beghé B; Fabbri LM; Garofalo M; Schito M; Verduri A; Bortolotti M; Stendardo M; Ruggieri V; Fucili A; Sverzellati N; Della Casa G; Maietti E; Clini EM; Boschetto P
Respiration; 2019; 97(3):223-233. PubMed ID: 30205380
[TBL] [Abstract][Full Text] [Related]
20. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
